Views & Analysis Adapting for the future of oncology External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace.
News Is Lilly about to swoop on Verve Therapeutics? Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
